학술논문
CAR T cells and time-limited ibrutinib as treatment for relapsed/refractory mantle cell lymphoma: the phase 2 TARMAC study
Document Type
Article
Author
Source
In: Blood . (Blood, 22 February 2024, 143(8):673-684)
Subject
Language
English
ISSN
15280020
00064971
00064971